Document is current
Any future updates will be listed below
-
Authors
Henry, N. L. https://orcid.org/0000-0002-4771-5930
Monkman, L. K.
Griffith, K.
Scheu, K.
Ghormley, T.
Armstrong, J.
Secor, M.
Jasthi, D.
Hawley, S. T.
Guetterman, T.
-
Funding
Funding for this research was provided by:
Rogel Cancer Center, University of Michigan
- License Information
-
More Information
Article History
Received: 29 October 2025
Accepted: 17 February 2026
First Online: 23 February 2026
Declarations
:
: NLH has received consultant honoraria from AstraZeneca, Daiichi Sankyo, and Genentech and royalties from Up-to-Date, none of which are relevant to this manuscript. No other authors have relevant financial interests to report.
: The University of Michigan Institutional Review Board granted an exemption #2 for this mixed methods study (HUM00262102).
: Verbal informed consent was obtained from all individual participants included in the study.
